Posts Tagged ‘células madre’

Thursday August 25th, 2016

New method creates for the first time kidney progenitor cells that survive in the lab

Salk scientists, in collaboration with Dr. Josep Maria Campistol, CEO and nephrologist of Hospital Clínic and Marta Lazo, IDIBAPS researcher, have managed to create and maintain renal structures through the use of a 3D culture and a new combination of signaling molecules. It is the first time that researchers succeed in maintaining a culture of Nephron Progenitor Cells (NPCs), which is an important boost to translational medicine and to research on the development of kidney disease and a further step towards the possibility of creating a transplantable kidney . The study, led by Dr. Juan Carlos Izpisua Belmonte, professor in Salk’s Gene Expression Laboratory, has been published in the journal Cell Stem Cell.

Read the rest of this entry »

Comments Closed
Friday July 29th, 2016

Stem cell therapy is effective for the treatment of fistulas in Crohn’s disease

A fat-derived stem cell therapy is effective for the treatment of fistulas in Crohn’s disease. A study published today in The Lancet, has shown that the treatment cures this lesions in 50% of patients, even in cases in which all therapeutic alternatives available fail. Thus, patients can avoid surgery. Dr. Julià Panés, Head of the Gastroenterology Department at Hospital Clínic and of the Inflammatory Bowel Disease IDIBAPS research team, is the principal investigator of the study, in which 49 hospitals in Europe and Israel collaborated. Dr. Damián García-Olmo, head of the Department of Surgery at the Hospital Fundación Jiménez Díaz-Quirónsalud Group, has established the surgical protocol for this study. This is the first Phase III study in the world to test cell therapy for fistulas in Crohn’s disease.

Read the rest of this entry »

Comments Closed

Categories

Posted in:

Tuesday April 28th, 2015

Discovered the genome regions responsible for pancreas formation

A group of researchers from IDIBAPS and the Imperial College London have developed, for the first time, a collection of the genome regions that contain the instructions for the pancreas development in the human embryo. There are included both the genes and those regions of the genome, called enhancers, that act as a kind of switches and play a key role in the genes activation or deactivation. The analysis of these switches has revealed a new mechanism that promotes the formation of the pancreas. In the article, published in the journal Nature Cell Biology, a model of stem cells differentiated to pancreatic progenitor cells, has also been validated which will facilitate the study of this organ in vitro from now on. Dr. Jorge Ferrer, head of the Genomic Programming of Beta Cells and Diabetes team at IDIBAPS and the Imperial College London, coordinates this study in which has also participated Dr. Meritxell Rovira, researcher in the same group at IDIBAPS.

Read the rest of this entry »

Comments Closed

Categories

Posted in:

Wednesday June 19th, 2013

Dr. Eduard Batlle explains the complexities of Colorectal Cancer in an IDIBAPS Seminar

Colorectal Cancer (CRC) is one of the leading causes of death by cancer worldwide. Dr. Eduard Batlle leads the Oncology Program and the Colorectal Cancer Laboratory at the Barcelona’s Institute for Research in Biomedicine (IRB), where they study the initiation of CRC and its progression from the early stages to the formation of invasive tumors. On Monday June 17th he offered an IDIBAPS Seminar titled “Understanding Colorectal Cancer as a Stem Cell hierarchy”. The Seminar was presented by Dr. Cristina Nadal, IDIBAPS investigator at the Molecular and translational oncology team that collaborated with Dr. Batlle in some of the results he presented. The Seminar turned out to be one of the recent sessions with the highest participation from the audience.

Read the rest of this entry »

Comments Closed

Categories

Posted in:

Wednesday February 29th, 2012

Bone marrow mononuclear cells prevent postinfarction dysfunction but its effect on chronic dysfunction is modest

Dr. Francisco Fernández-Avilés al Seminari IDIBAPS

Dr. Francisco Fernandez-Avilés offered on Monday February 20th an IDIBAPS Seminar about stem cell therapy for cardiac repair. He offered a wide perspective of the issue and the clinical implications of the latest researches he leads at the Hospital Universitario Gregorio Marañón. Dr. Josep Brugada, Medical Director of the Hospital Clínic of Barcelona and leader of an IDIBAPS research team, shared with him a speech that attracted a high number of investigators to the Esteve Auditorium of the CEK Building.

Read the rest of this entry »

Comments Closed

Categories

Posted in:

Wednesday June 03rd, 2009

Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma

five centres from Cataluny and Valencia are working toghether in the study

The Gamida Cell-Teva Joint Venture announced today that five prestigious cord blood transplantations centers in Spain, three in Barcelona and two in Valencia, have joined the ExCell study.

Read the rest of this entry »

Comments Closed
Page 1 of 212